Gapping up
In reaction to strong earnings/guidance:
- MATX +19.9% (guides Q2 EPS above consensus), GBX +12.8%, SLP +8% (also files mixed shelf offering), PSMT +5.8%, IART +3.6% (guides Q2 revs slightly below consensus)
Other news:
- ZIOP +4.6% (announces the initiation of a phase 1 trial to evaluate CD19-specific CAR-T using its RPM technology)
- EGO +2.9% (reports preliminary Q2 production of 137,782 gold ounces)
- VXX +1.3% (early strength with futures trading lower)
- EXPR +0.7% (Express provides update on its current business and latest store reopening plans - 95% of the company's stores are open and showing sequential improvement)
Analyst comments:
- BCS +3% (upgraded to Buy from Hold at Investec)
- SNBR +2.6% (upgraded to Overweight from Neutral at Piper Sandler)
- ALV +2.2% (initiated with a Buy at Goldman)
- NFLX +1.6% (target raised to Street-high $670 from $540 at Goldman)
- CAL +1.3% (upgraded to Positive from Negative at Susquehanna)
- FL +1.1% (upgraded to Positive from Neutral at Susquehanna)
- HOG +1% (upgraded to Sector Perform from Underperform at RBC Capital Mkts)
- RTX +1% (upgraded to Buy from Hold at Vertical Research)